期刊
JOURNAL OF ALZHEIMERS DISEASE
卷 81, 期 1, 页码 389-401出版社
IOS PRESS
DOI: 10.3233/JAD-201192
关键词
Alzheimer's disease pathology; biomarkers; cerebrospinal fluid; serum uric acid
资金
- National Natural Science Foundation of China [91849126, 81571245, 81771148]
- National Key R&D Program of China [2018YFC1314702]
- Qingdao Applied Basic Research Project [18-2-2-43-jch]
- Shanghai Municipal Science and Technology Major Project [2018SHZDZX03]
- ZJLab
The study found that elevated serum uric acid levels were associated with increased brain amyloid deposition in preclinical Alzheimer's disease, indicating a potential detrimental role of uric acid in AD pathology. Additionally, individuals with amyloid pathology had higher concentrations of uric acid, suggesting a possible link between uric acid levels and AD progression.
Background: Serum uric acid (SUA) affects the reaction of oxidative stress and free radicals in the neurodegenerative processes. However, whether SUA impacts Alzheimer's disease (AD) pathology remains unclear. Objective: We aimed to explore whether high SUA levels can aggravate the neurobiological changes of AD in preclinical AD. Methods: We analyzed cognitively intact participants (n = 839, age 62.16 years) who received SUA and cerebrospinal fluid (CSF) biomarkers (amyloid-beta [A beta], total tau [t-Tau], and phosphorylated tau [p-Tau]) measurements from the Chinese Alzheimer's Biomarker and LifestylE (CABLE) database using multivariable-adjusted linear models. Results: Levels of SUA in the preclinical AD elevated compared with the healthy controls (p = 0.007) and subjects with amyloid pathology had higher concentration of SUA than controls (p = 0.017). Roughly, equivalent levels of SUA displayed among cognitively intact individuals with or without tau pathology and neurodegeneration. CSF A beta(1-42) (p = 0.019) and A beta(1-42)/A beta(1-40) (p = 0.027) were decreased and CSF p-Tau/A beta(1-42) (p = 0.009) and t-Tau/A beta(1-42) (p = 0.043) were increased with the highest (> 75th percentile) SUA when compared to lowest SUA, implying a high burden of cerebral amyloidosis in individuals with high SUA. Sensitivity analyses using the usual threshold to define hyperuricemia and precluding drug effects yielded robust associations. Nevertheless, the quadratic model did not show any U-shaped relationships between them. Conclusion: SUA may aggravate brain amyloid deposition in preclinical AD, which corroborated the detrimental role of SUA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据